Shi Chen

Shi Chen

Auto-generated profile, based on publicly available information

Shi Chen

Chemical Biology Program, Memorial Sloan Kettering Cancer Center

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2012 in Organic Letters
Verified
Journal Article
Closed access
JHJiantao Hu
Jiantao Hu
SCShi Chen
Shi Chen
YSYonghui Sun
Yonghui Sun
JYJing Yang
Jing Yang
YRYu Rao
Yu Rao

13 May 2019 in eLife
Verified
Journal Article
Open access
SCShi Chen
Shi Chen
RWRafal P Wiewiora
Rafal P Wiewiora
Fanwang MengFanwang Meng
Fanwang Meng
NBNicolas Babault
Nicolas Babault
AMAnqi Ma
Anqi Ma
MLMinkui Luo
Minkui Luo
Elucidating the conformational heterogeneity of proteins is essential for understanding protein function and developing exogenous ligands. With the rapid development of experimental and computational methods, it is of great interest to integrate these approaches to illuminate the conformational landscapes of target proteins. SETD8 is a protein lysine methyltransferase (PKMT), which functions in vivo via the methylation of histone and nonhistone targets. Utilizing covalent inhibitors and depleting native ligands to trap hidden conformational states, we obtained diverse X-ray structures of SETD8. These structures were used to seed distributed atomistic molecular dynamics simulations that generated a total of six milliseconds of trajectory data. Markov state models, built via an automated machine learning approach and corroborated experimentally, reveal how slow conformational motions and conformational states are relevant to catalysis. These findings provide molecular insight on enzymatic catalysis and allosteric mechanisms of a PKMT via its detailed conformational landscape.

28 October 2019 in eLife
Verified
Journal Article
Open access
XCXiao-Chuan Cai
Xiao-Chuan Cai
TZTuo Zhang
Tuo Zhang
EKEui-Jun Kim
Eui-Jun Kim
MJMing Jiang
Ming Jiang
KWKe Wang
Ke Wang
MLMinkui Luo
Minkui Luo
CARM1 is a cancer-relevant protein arginine methyltransferase that regulates many aspects of transcription. Its pharmacological inhibition is a promising anti-cancer strategy. Here SKI-73 (6a in this work) is presented as a CARM1 chemical probe with pro-drug properties. SKI-73 (6a) can rapidly penetrate cell membranes and then be processed into active inhibitors, which are retained intracellularly with 10-fold enrichment for several days. These compounds were characterized for their potency, selectivity, modes of action, and on-target engagement. SKI-73 (6a) recapitulates the effect of CARM1 knockout against breast cancer cell invasion. Single-cell RNA-seq analysis revealed that the SKI-73(6a)-associated reduction of invasiveness acts by altering epigenetic plasticity and suppressing the invasion-prone subpopulation. Interestingly, SKI-73 (6a) and CARM1 knockout alter the epigenetic plasticity with remarkable difference, suggesting distinct modes of action for small-molecule and genetic perturbations. We therefore discovered a CARM1-addiction mechanism of cancer metastasis and developed a chemical probe to target this process.

22 February 2012 in Tetrahedron Letters
Verified
Journal Article
Closed access
PLPengfei Liu
Pengfei Liu
GSGang Shan
Gang Shan
SCShi Chen
Shi Chen
YRYu Rao
Yu Rao

2 December 2014 in Asian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
SCShi Chen
Shi Chen
GSGang Shan
Gang Shan
PNPengju Nie
Pengju Nie
YRYu Rao
Yu Rao

29 April 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SCShi Chen
Shi Chen
KKKanishk Kapilashrami
Kanishk Kapilashrami
CSChamara Senevirathne
Chamara Senevirathne
ZWZhen Wang
Zhen Wang
JWJunyi Wang
Junyi Wang
MLMinkui Luo
Minkui Luo